INC Research/inVentiv Health
3Q Revenues: $822.3 million (+110%)
3Q Loss: $148 million (earnings were $27.3 million 3Q16)
YTD Revenues: $1.6 billion (+32%)
YTD Loss: $123.4 million (earnings were $75.1 million YTD16)
Comments: INC Research completed the merger with inVentiv Health on August 1, 2017. Service revenue in the quarter was up 128% due to the Merger, partially offset by a decline in revenues due to continued customer and regulatory delays. Combined Clinical Solutions Segment generated revenue of $533.4 million in the quarter. Combined Commercial Solutions Segment generated revenue of $233.2 million. Results include the impact of Merger-related transaction expenses of $84.3 million and $108.1 million, respectively, an impairment charge of $30 million in 3Q17, and an increase in amortization expense of $41.9 million in both periods due to the acquisition of intangible assets as a result of the Merger.